Division of Oncology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria.
J Clin Pathol. 2012 Aug;65(8):721-4. doi: 10.1136/jclinpath-2012-200797. Epub 2012 May 25.
To analyse renal cell carcinoma (RCC) stage, grade, histology and necrosis migration in a large European centre series over the last 27 years.
The pathology reports of 2739 consecutive patients with RCC who underwent nephrectomy from 1984 to 2010 at the institution of the authors were systematically re-evaluated. Patients were pooled into five time groups according to the date of surgery: group 1: 1984-1989, group 2: 1990-1994, group 3: 1995-1999, group 4: 2000-2004 and group 5: 2005-2010, respectively. Changes in pT categories according to WHO 2010 classification, tumour grade, histological subtype and presence of tumour necrosis (TN) were evaluated.
Small pT1a tumours were found in 62/485 (12.8%) and 312/639 (48.8%) patients in groups 1 and 5, respectively (p<0.001). Advanced tumour stages (pT3a-4) were found in 306/485 (63.1%) and 171/639 (26.8%) patients in groups 1 and 5, respectively (p<0.001). The number of grade 3/4 tumours increased from 62/485 (12.7%) and 130/639 (20.3%) in groups 1 and 5, respectively, whereas the number of grade 1 tumours decreased over time (p<0.001). There has been a significant histological migration for the chromophobe subtype from 1.1% to 4.3% (p=0.002). The frequency of the presence TN decreased from 41.7% in group 1 to 32.7% in group 5 (p<0.001).
In contrast to data from Australia but similar to data from US cohorts, a statistically significant stage migration towards small RCCs was observed in this European cohort. Significant changes in tumour grade, histological subtype and TN were also observed.
分析过去 27 年来,在一家大型欧洲中心的一系列病例中,肾细胞癌(RCC)的分期、分级、组织学和坏死转移情况。
系统性地重新评估了 1984 年至 2010 年间在作者所在机构接受肾切除术的 2739 例连续 RCC 患者的病理报告。患者根据手术日期分为五组:第 1 组:1984-1989 年;第 2 组:1990-1994 年;第 3 组:1995-1999 年;第 4 组:2000-2004 年;第 5 组:2005-2010 年。评估了根据世界卫生组织 2010 年分类的 pT 类别、肿瘤分级、组织学亚型和肿瘤坏死(TN)的变化。
第 1 组和第 5 组分别有 62/485(12.8%)和 312/639(48.8%)例患者为小 pT1a 肿瘤(p<0.001)。第 1 组和第 5 组分别有 306/485(63.1%)和 171/639(26.8%)例患者为晚期肿瘤分期(pT3a-4)(p<0.001)。第 1 组和第 5 组的 3/4 级肿瘤数量分别从 62/485(12.7%)和 130/639(20.3%)增加,而 1 级肿瘤的数量随着时间的推移而减少(p<0.001)。嗜铬细胞瘤亚型的发生率从 1.1%增加到 4.3%(p=0.002)。第 1 组的 TN 发生率为 41.7%,而第 5 组的 TN 发生率为 32.7%(p<0.001)。
与澳大利亚的数据相反,但与美国队列的数据相似,在这个欧洲队列中观察到了向小 RCC 显著的分期转移。肿瘤分级、组织学亚型和 TN 也发生了显著变化。